<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: We have previously shown that female animals experience substantial protection from brain injury after reversible middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) compared with their male or ovariectomized female counterparts </plain></SENT>
<SENT sid="1" pm="."><plain>The reproductive steroid <z:chebi fb="0" ids="50114">estrogen</z:chebi> has been shown to provide neuroprotection from a variety of experimental insults, but the importance of <z:chebi fb="28" ids="17026">progesterone</z:chebi> as an anti-ischemic treatment has not been well explored </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated histological outcomes after MCAO in ovariectomized female rats with or without <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="28" ids="17026">progesterone</z:chebi> replacement therapy </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Age-matched, adult female Wistar rats were ovariectomized and treated with 0, 30, or 60 mg/kg <z:chebi fb="28" ids="17026">progesterone</z:chebi> IP 30 minutes before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (n=12 to 14 per group) or with 30 mg/kg <z:chebi fb="28" ids="17026">progesterone</z:chebi> IP daily for 7 to 10 days before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (n=16) </plain></SENT>
<SENT sid="4" pm="."><plain>Each animal subsequently underwent 2 hours of MCAO with the intraluminal filament technique, followed by 22 hours of reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>Ipsilateral parietal cortex perfusion was monitored with laser Doppler flowmetry throughout <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Cortical, caudate-putamen, and hemispheric infarction volumes were determined with 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining and digital image analysis </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Intraischemic plasma <z:chebi fb="28" ids="17026">progesterone</z:chebi> levels were 5+/-3, 102+/-20,* 181+/-28,* and 133+/-25* ng/mL in the 0, 30, and 60 mg/kg <z:hpo ids='HP_0011009'>acute</z:hpo> <z:chebi fb="28" ids="17026">progesterone</z:chebi> group and the 30 mg/kg <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="28" ids="17026">progesterone</z:chebi> group, respectively (*P&lt;0.05 compared with 0 mg/kg) </plain></SENT>
<SENT sid="8" pm="."><plain>Caudate-putamen infarction volume (percent contralateral structure) was significantly increased by <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="28" ids="17026">progesterone</z:chebi> treatment: 45.6+/-5.1%* in the 30 mg/kg <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="28" ids="17026">progesterone</z:chebi> group and 29.2+/-5.3%, 35.8+/-5.1%, and 42.0+/-5.0% in the 0, 30, and 60 mg/kg <z:hpo ids='HP_0011009'>acute</z:hpo> <z:chebi fb="28" ids="17026">progesterone</z:chebi> groups, respectively (*P&lt;0.05 compared with 0 mg/kg) </plain></SENT>
<SENT sid="9" pm="."><plain>Cortical and total hemispheric infarction volumes (percent contralateral structure) were unchanged by <z:chebi fb="28" ids="17026">progesterone</z:chebi> treatment </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Exogenous <z:chebi fb="28" ids="17026">progesterone</z:chebi> therapy does not ameliorate histological injury after MCAO in previously ovariectomized, adult female rats </plain></SENT>
<SENT sid="11" pm="."><plain>Furthermore, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="28" ids="17026">progesterone</z:chebi> administration can exacerbate infarction in subcortical regions </plain></SENT>
</text></document>